Diagnostic challenges in non-cirrhotic portal hypertension-porto sinusoidal vascular disease

被引:0
|
作者
Oana Nicoar?-Farc?u
Ioana Rusu [1 ,3 ]
Horia Stef?nescu
Marcel Tant?u
Radu Ion Badea [1 ,4 ]
Bogdan Procopet [1 ,2 ]
机构
[1] University of Medicine and Pharmacy “Iuliu Hatieganu”
[2] Gastroenterology Department, Regional Institute of Gastroenterology and Hepatology “O. Fodor”
[3] Pathology Department, Regional Institute of Gastroenterology and Hepatology “O.Fodor”
[4] Imagistic Department, Regional Institute of Gastroenterology and Hepatology “O. Fodor”
关键词
Porto-sinusoidal vascular disease; Extrahepatic portal vein obstruction; Noncirrhotic portal hypertension; Non-invasive diagnosis; Idiopathic portal hypertension; Cirrhosis;
D O I
暂无
中图分类号
R575.2 [肝硬变]; R543.6 [静脉疾病];
学科分类号
1002 ; 100201 ;
摘要
Non-cirrhotic portal hypertension consists of a group of diseases characterized by signs and complications of portal hypertension,which differ from cirrhosis through histological alterations,hemodynamic characterization and, clinical outcome.Because of the similarities in clinical presentation and imaging signs,frequently these patients,and particularly those with porto-sinusoidal vascular disease(PSVD), are misdiagnosed as having liver cirrhosis and thus raising difficulties in their diagnosis.The most challenging differentiation to be considered is between PSVD and cirrhosis and, although not pathognomonic,liver biopsy is still the standard of diagnosis.Although they still require extended validation before being broadly used,new non-invasive methods for the diagnosis of porto-sinusoidal vascular disease,like transient elastography,contrast-enhanced ultrasound or metabolomic profiling,have shown promising results.Another issue is the differentiation between PSVD and chronic extrahepatic portal vein obstruction,especially now when it is known that 40% of patients suffering from PSVD develop portal vein thrombosis.In this particular case,once the portal vein thrombosis occurred,the diagnosis of PSVD is impossible according to the current guidelines.Moreover,so far,the differentiation between PSVD and sinusoidal obstruction syndrome has not been dear so far in particular circumstances.In this review we highlighted the diagnostic challenges regarding the PSVD, as well as the current techniques used in the evaluation of these patients.
引用
收藏
页码:3000 / 3011
页数:12
相关论文
共 50 条
  • [31] Idiopathic Non-Cirrhotic Portal Hypertension and Fibrosis
    Babu Lal Meena
    Shiv Kumar Sarin
    Current Hepatology Reports, 24 (1)
  • [32] ARSENIC AND NON-CIRRHOTIC PORTAL-HYPERTENSION
    MORRIS, JS
    SCHMID, M
    NEWMAN, S
    SCHEUER, PJ
    SHERLOCK, S
    GUT, 1973, 14 (10) : 821 - 821
  • [33] Pathology of idiopathic non-cirrhotic portal hypertension
    Masayoshi Kage
    Hepatology International, 2017, 11 : 409 - 411
  • [34] ARSENIC AND NON-CIRRHOTIC PORTAL-HYPERTENSION
    MORRIS, JS
    SCHMID, M
    NEWMAN, S
    SCHEUER, PJ
    SHERLOCK, S
    DIGESTION, 1973, 8 (05) : 441 - 441
  • [35] Non-cirrhotic portal hypertension: an imaging review
    Rajesh, S.
    Mukund, Amar
    Sureka, Binit
    Bansal, Kalpana
    Ronot, Maxime
    Arora, Ankur
    ABDOMINAL RADIOLOGY, 2018, 43 (08) : 1991 - 2010
  • [36] Rare cause of non-cirrhotic portal hypertension
    Song, Danping
    Gao, Bingxia
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 840 - 840
  • [37] Pathology of idiopathic non-cirrhotic portal hypertension
    Maria Guido
    Samantha Sarcognato
    Diana Sacchi
    Guido Colloredo
    Virchows Archiv, 2018, 473 : 23 - 31
  • [38] Massive Splenomegaly With Non-Cirrhotic Portal Hypertension
    Kundrotas, Leon W.
    Horne, Caroline
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1982 - S1982
  • [39] Idiopathic non-cirrhotic portal hypertension: a review
    Schouten, Jeoffrey N. L.
    Verheij, Joanne
    Seijo, Susana
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [40] Hepatic encephalopathy in non-cirrhotic portal hypertension
    Meena, Babu Lal
    Narayan, S. J. Ananthu
    Sarin, Shiv Kumar
    METABOLIC BRAIN DISEASE, 2025, 40 (01)